Stock Alert: Biomerica Adds 14%

Shares of Biomerica, Inc. (BMRA) are rising more than 14% Tuesday morning after the company said it submitted Emergency Use Authorization (EUA) application to the FDA for its ELISA lab-based serology antibody test for Covid-19.

Biomerica has filed a provisional patent on technology to allow simplified blood collection.

The company also intends to obtain a CE mark to sell ELISA laboratory test outside the US.

BMRA is currently trading at $6.12. It has traded in the range of $2.05- $23.39 in the last 52 weeks.

20 Indian soldiers killed in border clashes with China, says army

The Indian army says 20 of its soldiers have been in killed in border clashes with China.

Marcus Rashford prompts government U-turn on free school meals

On this edition of the Sky News Daily podcast with Dermot Murnaghan, we examine the impact of the England footballer’s campaign and discuss how children have been treated during the COVID-19 pandemic.

We are joined by our political correspondent Tamara Cohen, football coach Dave Horrocks and the YMCA’s Alan Fraser.

Plus, Dr Kojo Koram – law lecturer at Birkbeck School of Law – and comedian Andrew Doyle talk to us about the portrayal of black people in entertainment following Black Lives Matter protests.

Merkel expects decisions on future EU finances in July -sources

BERLIN, June 16 (Reuters) – German Chancellor Angela Merkel does not expect European Union leaders to reach an agreement on the bloc’s future finances at a summit on Friday, participants at a meeting of her conservative parliamentary bloc said on Tuesday.

Rather, Merkel expects decisions on the so-called Recovery Fund and the bloc’s multi-year financial framework through to 2027 to be agreed in July, the participants said.

They said Merkel told Tuesday’s meeting that the economic fallout from the coronavirus pandemic meant: “There’s a huge mountain of work ahead of us.”

UK continuing drug trials to improve on COVID-19 steroid treatment

LONDON (Reuters) – Britain is continuing medical trials to see if it can combine other drugs with a steroid treatment shown to reduce deaths among some COVID-19 patients, Chief Scientific Adviser Patrick Vallance said on Tuesday.

“This is the start of something important,” he said. “It shows it is possible to reduce the inflammation and the outcome in patients with lung disease in hospital, and it’s the start of other drugs which might be added on top of it to make an even bigger effect.”

Adidas Plans To Fill At Least 30% Of New U.S. Jobs With Black And Latinx People

Adidas will increase the number of black employees in its North American workforce and also increase the funding for black communities, amid recent protests over the death of George Floyd at the hands of Minneapolis police.

“The events of the past two weeks have caused all of us to reflect on what we can do to confront the cultural and systemic forces that sustain racism”, said adidas CEO Kasper Rorsted.

The German sportswear giant said it plans to fill at least 30% of new positions in the US at adidas and Reebok with black and Latinx people.

The initiatives come after black employees reportedly demanded more investment in the black community from the company.

The company will also announce a target aimed at increasing representation of Black and Latinx people within its workforce in North America.

The company said it will invest $20 million in black communities in the U.S. over the next four years.

The funding initiatives include adidas Legacy, a grassroots basketball platform built for underserved communities; the adidas School for Experiential Education in Design that creates career paths in footwear design; Honoring Black Excellence, an initiative honoring and supporting the Black community through sport.

The company will finance 50 university scholarships each year for black students over the next five years.

Stock Alert: Biomerica Adds 14%

Shares of Biomerica, Inc. (BMRA) are rising more than 14% Tuesday morning after the company said it submitted Emergency Use Authorization (EUA) application to the FDA for its ELISA lab-based serology antibody test for Covid-19.

Biomerica has filed a provisional patent on technology to allow simplified blood collection.

The company also intends to obtain a CE mark to sell ELISA laboratory test outside the US.

BMRA is currently trading at $6.12. It has traded in the range of $2.05- $23.39 in the last 52 weeks.

FCC demands answers after nationwide T-Mobile outage

Federal regulators have vowed to get to the bottom of a widespread T-Mobile network outage that left customers across the country with no cell service.

Federal Communications Commission chairman Ajit Pai on Monday tweeted that the FCC would be “launching an investigation.”

“The T-Mobile network outage is unacceptable,” Pai wrote. “We’re demanding answers – and so are American consumers.”

The outage began at noon on Monday and lasted roughly 12 hours.  Neville Ray, president of technology at T-Mobile, said on Twitter Monday that engineers had been working to resolve a voice and data issue.

He said later that data services were now available and some calls were completing. “Alternate services like WhatsApp, Signal, iMessage, Facetime etc. are available,” he added.

The announcement of the probe arrived as CNBC reported that Japanese conglomerate SoftBank was looking to sell two-thirds of its stake in the carrier, worth as much as $20 billion.

In 2018, Pai backed the merger of T-Mobile and Sprint Corp saying it would lead to improved 5G coverage in the United States and would bring much faster mobile broadband to rural Americans.

T-Mobile on April 1 officially completed its $23 billion merger with Sprint, solidifying its position as the No.3 wireless providers in the United States.

With Post wires